Page 5 - Congenital Anomalies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Congenital anomalies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Congenital Anomalies Today - Breaking & Trending Today

ProKidney (PROK) to Release Quarterly Earnings on Friday

ProKidney (NASDAQ:PROK – Get Free Report) is set to release its earnings data on Friday, August 4th. ProKidney (NASDAQ:PROK – Get Free Report) last announced its quarterly earnings data on Thursday, May 11th. The company reported ($0.16) EPS for the quarter. On average, analysts expect ProKidney to post $-1 EPS for the current fiscal year […] ....

United States , Prokidney Company Profile , Vanguard Group Inc , Blackrock Inc , Prokidney Corp , Geode Capital Management , America Corp , Morgan Stanley , Get Free Report , Kidney Trading Down , Capital Management , Kidney Corp , Renal Autologous Cell Therapy , Congenital Anomalies , Urinary Tract , Prokidney Daily , Nasdaq Prok ,

ProKidney (PROK) to Release Quarterly Earnings on Friday

ProKidney (NASDAQ:PROK – Get Free Report) is set to release its earnings data on Friday, August 4th. ProKidney (NASDAQ:PROK – Get Free Report) last announced its quarterly earnings data on Thursday, May 11th. The company reported ($0.16) EPS for the quarter. On average, analysts expect ProKidney to post $-1 EPS for the current fiscal year […] ....

United States , America Corp , Morgan Stanley , Geode Capital Management , Prokidney Corp , Vanguard Group Inc , Prokidney Company Profile , Blackrock Inc , Get Free Report , Kidney Trading Down , Capital Management , Kidney Corp , Renal Autologous Cell Therapy , Congenital Anomalies , Urinary Tract , Prokidney Daily ,

ProKidney (NASDAQ:PROK) Trading Down 4%

ProKidney Corp. (NASDAQ:PROK – Get Free Report) dropped 4% during mid-day trading on Tuesday . The company traded as low as $11.31 and last traded at $11.38. Approximately 53,859 shares were traded during mid-day trading, a decline of 80% from the average daily volume of 264,994 shares. The stock had previously closed at $11.86. ProKidney […] ....

United States , Brown University , Morgan Stanley , Vanguard Group Inc , Prokidney Corp , Capital Group , America Corp , Get Free Report , Vanguard Group , Kidney Corp , Renal Autologous Cell Therapy , Congenital Anomalies , Urinary Tract , Prokidney Daily , Nasdaq Prok ,

ProKidney Corp. (NASDAQ:PROK) Sees Large Growth in Short Interest

ProKidney Corp. (NASDAQ:PROK – Get Free Report) was the target of a significant growth in short interest in June. As of June 30th, there was short interest totalling 6,280,000 shares, a growth of 44.4% from the June 15th total of 4,350,000 shares. Approximately 36.9% of the company’s stock are short sold. Based on an average […] ....

Prokidney Corp , Group Plc , Tower Research Capital , Get Free Report , Research Capital , General Group Plc , Point Capital Management , Kidney Corp , Renal Autologous Cell Therapy , Congenital Anomalies , Urinary Tract , Prokidney Daily , Nasdaq Prok ,

Russia bans gender reassignment

The Russian State Duma has passed a law banning gender reassignment in the final reading. Source: Kremlin-aligned Russian news agency RIA Novosti Details: According to the draft law, "medical workers are prohibited from performing medical interventions aimed at changing the sex of an individual - in particular, the formation of primary and (or) secondary sexual characteristics of the other sex in a person. ....

United States , Vladimir Putin , Russian State Duma , Kremlin Aligned Russian , State Duma , Gender Reassignment , Secondary Sexual Characteristics , Medical Workers , Congenital Anomalies , Russian News Agency ,